NM_015512.5:c.6203C>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_015512.5(DNAH1):c.6203C>G(p.Thr2068Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000075 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T2068T) has been classified as Benign.
Frequency
Consequence
NM_015512.5 missense
Scores
Clinical Significance
Conservation
Publications
- spermatogenic failure 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- ciliary dyskinesia, primary, 37Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic male infertility due to sperm motility disorderInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH1 | NM_015512.5 | c.6203C>G | p.Thr2068Ser | missense_variant | Exon 39 of 78 | ENST00000420323.7 | NP_056327.4 | |
DNAH1 | XM_017006129.2 | c.6272C>G | p.Thr2091Ser | missense_variant | Exon 41 of 80 | XP_016861618.1 | ||
DNAH1 | XM_017006130.2 | c.6203C>G | p.Thr2068Ser | missense_variant | Exon 40 of 79 | XP_016861619.1 | ||
DNAH1 | XM_017006131.2 | c.6272C>G | p.Thr2091Ser | missense_variant | Exon 41 of 79 | XP_016861620.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 249212 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461694Hom.: 0 Cov.: 32 AF XY: 0.0000633 AC XY: 46AN XY: 727126 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74344 show subpopulations
ClinVar
Submissions by phenotype
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 2068 of the DNAH1 protein (p.Thr2068Ser). This variant is present in population databases (rs138341550, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 544615). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DNAH1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The c.6203C>G (p.T2068S) alteration is located in exon 39 (coding exon 38) of the DNAH1 gene. This alteration results from a C to G substitution at nucleotide position 6203, causing the threonine (T) at amino acid position 2068 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at